作者: Morten Høyer , Anand Swaminath , Sean Bydder , Michael Lock , Alejandra Méndez Romero
DOI: 10.1016/J.IJROBP.2011.07.020
关键词:
摘要: Over the past decade, there has been an increasing use of radiotherapy (RT) for treatment liver metastases. Most often, ablative doses are delivered to focal metastases with goal local control and ultimately improving survival. In contrast, low-dose whole-liver RT may be used palliation symptomatic diffuse This review examines available clinical data both approaches. The found that is effective ablation patients However, a lack high level evidence from randomized trials.